THE INTERNATIONAL MYELOMA FOUNDATION LAUNCHES THE BLACK SWAN RESEARCH INITIATIVE™ TO DEVELOP THE VERY FIRST DEFINITIVE CURE FOR MULTIPLE MYELOMA —The Initiative Aims to
Read more →Tackling Myeloma at the 54th Annual Meeting of the American Society of Hematology (ASH) The Tackle Cancer Foundation played a special role at this
Read more →THE TACKLE CANCER FOUNDATION SAYS 71-YEAR-OLD MYELOMA PATIENT POISED TO REACH HIS GOAL OF A MARATHON IN ALL 50 STATES DECEMBER 9TH IN HAWAII —So
Read more →Pomalidomide, Being Tested for Multiple Myeloma, Improves Overall Survival in Patients in a Clinical Trial Dallas, TX, October 24, 2012 – Leaders of the Tackle
Read more →Marathon runners share passion Record holder, 29, cancer fighter, 71, both face pressure http://www.argusleader.com/apps/pbcs.dll/article?AID=2012309080024 11:57 PM, Sep 7, 2012 By Peter Harriman This is a
Read more →Blood Cancer Awareness Month: September 2012 Someone in the U.S. is diagnosed with a blood cancer every 4 minutes. Many know nothing about blood cancers
Read more →71-YEAR-OLD CANCER PATIENT TO RUN ALASKA MARATHON ON WAY TO ALL 50 STATES —63 Marathons in 44 States Completed Since Cancer Diagnosis; Over 1,500
Read more →THE INTERNATIONAL MYELOMA FOUNDATION SAYS THREE STUDIES HIGHLIGHTING MYELOMA TREATMENT-ADVANCES ARE FEATURED TOGETHER IN THE PRESTIGOUS NEW ENGLAND JOURNAL OF MEDICINE - Studies Cover REVLIMID Continuous
Read more →THE INTERNATIONAL MYELOMA FOUNDATION APPLAUDS DELAWARE AND VIRGINIA LEGISLATURES FOR PASSING ORAL DRUG PARITY BILLS – Actions in Two States Represent the Latest in Line
Read more →THE INTERNATIONAL MYELOMA FOUNDATION SAYS POMALIDOMIDE, AN IMPORTANT NEW DRUG FOR PATIENTS, HAS BEEN SUBMITTED FOR FDA APPROVAL – Accelerated Review Could Make the Drug
Read more →
